European Bankers Aren’t Bankers

Title says it. European bankers are not bankers. The largest deals in Europe are smaller and less complex than me buying my brothers lemonade stand when I was 8.

Watching Europeans call themselves bankers is like watching my nephew call himself a fireman as I sit on the porch and tell him which plants to point the hose at next.

Europe is an open air theme park full of toddlers playing “grown-up.” We subsidize their healthcare and militaries. Keep biking around your walkable cities talking about what to tax next. Let us handle the banking.

34 Comments
 
Funniest

”We subsidize their healthcare" Well not really. 

99% of us are in it for the money, a few years in your career and you'll realise on your own that it was never about calling ourselves Bankers and that "prestige"/social status don't mean shit. 

Sure, the average Deal $EV in Europe is smaller, but the bottom line is really being in the 0.5% of earners in your age group which IB/PE allows here (even with a 30% comp discount relative to US Bankers). Combine that with almost 2 months of PTO/y & cheap flights across the entirety of Europe and you've got a pretty good life. 

For the 1% of Euro hardos wanting to work on bigger deals, they always have the possibility of moving to the States and honestly fair play to them. At age 60, I'm sure they'll be happy to retire with an added USD5mm in Net Worth. 

From your post history: 

It seems like you should self reflect a bit. 

 

They do subsidise our healthcare. European countries pay far less for drugs than the US, when the vast majority of R&D is done out of the states, which makes no sense. How is it fair for us to pay far less for drugs created in the US? If trumps pharma exec order actually becomes reality then all of European healthcare is completely fucked

 

No Analyst 2 in HF - Event, that is just factually incorrect. 

U.S. drug prices are high because the US forbade Medicare to negotiate, not because Europe underpays. We still buy ~20 % of the world’s meds. Price gaps just reflect each market’s rules—Europe uses health-technology assessments and reference pricing, the U.S. largely did not until the IRA. 

Drug discovery is also shared as even if America funds a bit more than half of private R&D, Euro firms and public programmes still invest tens of billions and have produced massive breakthroughs (BioNTech’s mRNA, Novartis’s CAR-T etc)

“Fairness” is simply different choices where Americans accept higher prices for faster access through Supply & Demand Dynamics; Europeans accept tighter controls for affordability.

Trump-style “most-favoured-nation” pricing would cap U.S. reimbursements at the lowest OECD level; it cannot force Europe to pay more, and similar rules were already blocked in U.S. courts. Lower U.S. prices would just squeeze pharma margins, not unravel European healthcare.

 

Yea and then let’s see your pretzel neck obese MD struggle to breathe while he pitches it. Meanwhile bocconi giga chad wins the mandate without getting to slide 2

 
[Comment removed by mod team]
 

how you even dare to point out a factually accurate observation where the #1 place isn't US/related to US?

rest assured that this comment was flagged by the CIA because of this, so consider yourself under a watch list

incentives triumph ethics
 

Culpa suscipit aut dolores aut aspernatur. Delectus temporibus et aperiam possimus id commodi earum. Ullam nostrum vel nulla eum quisquam libero. Ut quidem inventore laudantium. Est labore expedita fuga delectus illo. Enim consequatur optio non quam molestiae porro magni. Atque ut corporis dolore et laborum dolorem. Recusandae nihil dolorem ut qui minus.

Est excepturi beatae molestiae corporis quisquam explicabo. Veritatis pariatur voluptatibus officiis. Sit officia cumque corrupti est.

Explicabo error ut quis sit fugit. Ut omnis commodi cum hic porro. Ut sed et dolor ullam excepturi dolor adipisci fuga. Vel et animi possimus alias.

Occaecati magnam tempore et et sed qui. Libero quod dolor quo explicabo. Voluptas ullam qui dolores sint velit dolorum voluptatem fuga.

 

Quis impedit sint qui blanditiis. Qui esse perferendis harum velit dolores. Et est dolor fugiat repudiandae.

Consectetur sequi pariatur rem illo eum. Neque voluptas repellendus omnis sit voluptatum ipsum sit porro. Unde dignissimos quasi rerum id asperiores maiores et.

Iure iusto magni dolorem iusto voluptates assumenda. Accusamus minus aut quia aut impedit nostrum. Eaque quo quo earum veritatis.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
CompBanker's picture
CompBanker
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
dosk17's picture
dosk17
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”